The cold and flu supplements market was valued at USD 24.65 billion in 2026, expanding at a CAGR of 12.03% by 2035. The market is driven by rising consumer focus on immune health, increasing demand for natural remedies, and growing use of supplements for seasonal cold and flu symptom support. Key trends include adoption of botanical ingredients, combination formulations, gummies, powders, and convenient liquid formats. Growing preventive healthcare awareness, e-commerce penetration, and demand for evidence-backed immune-support products are expected to create new opportunities for manufacturers through 2035.
